Caffeine is a widely used naturally occurring cognitive enhancer, yet none of its effects on synaptic transmission described thus far are overt. The effects of caffeine on cognition are mediated primarily by blockade of the A 1 R, and antagonists of A 1 Rs enhance induction and stability of long-term potentiation (LTP) in hippocampal CA1 (refs. 1,2). A 1 Rs, however, are most highly enriched in CA2 (ref.
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Caffeine is a widely used naturally occurring cognitive enhancer, yet none of its effects on synaptic transmission described thus far are overt. The effects of caffeine on cognition are mediated primarily by blockade of the A 1 R, and antagonists of A 1 Rs enhance induction and stability of long-term potentiation (LTP) in hippocampal CA1 (refs. 1,2) . A 1 Rs, however, are most highly enriched in CA2 (ref. 3) , suggesting a unique role for this region in mediating the effects of caffeine. Schaffer collateral synapses in CA2 differ substantially from others in the hippocampus in that they enigmatically fail to exhibit activity-dependent LTP 4 , largely as a result of higher calcium buffering and extrusion and the presence of RGS14 in CA2 pyramidal neurons 5, 6 . We therefore examined whether caffeine differentially influences synaptic strength in CA2. To do this, we prepared hippocampal slices from juvenile rats 1 h after they had been orally administered one of three doses of caffeine representing different levels of human use: 2 mg per kg of body weight (two large cups of coffee), 6.5 mg per kg (one highly caffeinated energy drink) or 20 mg per kg (a dose that exceeds most people's daily intake; Supplementary Methods). Regardless of dose, caffeine induced a persistent increase in synaptic responses in CA2, but not in CA1 (Fig. 1a-f ). In addition, neuronal excitability was unaffected by caffeine ( Fig. 1g-i) , suggesting that the enhanced transmission in CA2 was a result of modifications at synapses. Although previous studies have shown that adenosine antagonists modulate LTP induction 1, 7 , this is, to the best of our knowledge, the first demonstration of long-lasting plasticity induced solely by in vivo exposure to caffeine. These findings also identify synapses in CA2 as a target of caffeine.
To control for possible indirect effects of caffeine, such as those on blood flow, and to further address the mechanisms of the enhancement, we applied caffeine directly to hippocampal slices ( Fig. 2) and found that even a brief exposure induced an immediate and lasting facilitation of CA2 responses (juvenile slices; Fig. 2a ; adult slices, Supplementary Fig. 1a,c) . Similar results were not observed in CA1. To better assess the persistence of the facilitation, we exposed slices to caffeine for 5 min and then returned them to a holding chamber for either 1, 2 or 3 h before carrying out whole-cell recordings. Synaptic responses were enhanced for at least 3 h post-treatment (Fig. 2b) . We attribute the caffeine-induced potentiation in CA2 to blockade of A 1 Rs because other, more selective A 1 R antagonists, such as DPCPX (10 nM, juvenile; Fig. 2c; adult; Supplementary Fig. 1b,d ), PSB 36 (10 nM, data not shown) and CPT (100 nM; Fig. 2h) , induced a similar potentiation (hereafter termed A 1 R-P). As with caffeine, DPCPX failed to induce lasting effects on transmission in CA1 or CA3 (CA1; Fig. 2c and Supplementary Fig. 1b,d ; CA3; Supplementary  Fig. 1e,f) , but both caffeine and CPT potentiated responses in CA1 if the concentrations that were applied were substantially higher, as shown previously 8 (300 µM caffeine, 1 µM CPT; Fig. 2e-h ). These findings suggest that, when low concentrations of A 1 R antagonists are used, enhancement is observed only in CA2.
Phosphodiesterases (PDEs) can be inhibited by caffeine, albeit at much higher doses than those used here 9 , so we tested whether a broad-spectrum PDE inhibitor would mimic the effects observed with caffeine. It did not, indicating that caffeine's actions were not likely the result of preferential PDE inhibition in CA2 ( Supplementary  Fig. 2a) . A 1 Rs acting presynaptically are similarly unlikely to account for A 1 R-P in CA2: differences in paired-pulse facilitation in CA2 during DPCPX application differed little from the effects observed in CA1 (data not shown) 2, 10 , consistent with the finding that A 1 R immunoreactivity in CA2 does not co-localize with presynaptic markers 3 . In addition, blockade of GABA A -mediated transmission or performing experiments at 32 °C did not affect the magnitude of A 1 R-P induced by caffeine or DPCPX in CA2 (data not shown).
To further investigate the mechanisms underlying A 1 R-P at CA2 synapses ( Fig. 3) , we tested whether A 1 R-P shared properties with tetanus-induced LTP. A 1 R-P did not require synaptic stimulation during drug application, nor was it sensitive to the NMDAR antagonist d(-)-2-amino-5-phosphonovaleric acid (AP5) or intracellular calcium chelation with BAPTA ( Fig. 3a-c) . Inhibition of CaMKII (10 µM KN62; Fig. 3c ), PKC and PKM (500 nM Go6983, data not shown) or PI3 kinase (100 nM Wortmannin, data not shown) was also ineffective at blocking A 1 R-P. These data indicate that the calcium-dependent mechanisms required for LTP induction in CA1 are either bypassed or are unnecessary in A 1 R-P in CA2. They also argue against a critical role for ryanodine receptor-mediated increases in postsynaptic calcium 11 .
Consistent with A 1 Rs being coupled to the G i/o family of G proteins, which, when activated, inhibit adenylyl cyclases, several variants of adenylyl cyclase are highly enriched in CA2 Supplementary Fig. 2b ). Thus as might be expected, A 1 R-P was blocked by loading CA2 neurons with inhibitors of adenylyl cyclase or PKA (SQ22536 or PKI; Fig. 3e,f; 10 µM MDL-12,330A or 1 µM KT 5720, data not shown). Bath application of U0126, a specific inhibitor of MEK (or the ERK inhibitor FR 180204, 2 µM, data not shown), blocked the stabilization of A 1 R-P, but not its earliest phase (Fig. 3d) , suggesting a possible role of the Ras-MAPK pathway in A 1 R-P consolidation. In addition, the DPCPX-mediated potentiation of synaptic responses in CA2 is correlated with an increase in the volume of spines located on the branches of secondary and tertiary apical dendrites in CA2 neurons ( Supplementary  Fig. 2c-e) . Together, these findings indicate that induction of 
A 1 R-P in CA2 neurons is postsynaptic and is mediated through cAMP-dependent activation of PKA. ERK-MAP kinase is likely required for its consolidation. Adenosine in the brain is thought to rise throughout the day and to be cleared during sleep 2 . Our results support the hypothesis that the use of caffeine provides temporary increases in mental acuity by blocking the normal inhibitory effects of adenosine. The role of CA2 in brain function is unknown, but clues may be gleaned by the finding that the number of nonpyramidal (inhibitory) neurons is reduced in the CA2 of individuals with schizophrenia 12 and that caffeine has been observed to worsen symptoms of psychosis 13 . Notably, knockout of a vasopressin receptor enriched in CA2 produces mice with impairments in social recognition memory 14 and caffeine enhances this kind of memory in rodents 15 . Thus, the robust potentiation induced by caffeine exposure both in vivo and in vitro strongly suggests that A 1 R-P in CA2 is the physiological substrate for the cognitive enhancement provided by caffeine consumption. 
